FORTIS HEALTHCARE
|
FORTIS HEALTHCARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 7.93 | 7.80 | 7.35 | -1.45 | 0.77 |
| CEPS(Rs) | 13.08 | 12.57 | 14.45 | 3.11 | 5.08 |
| DPS(Rs) | 1.00 | 1.00 | - | - | - |
| Book NAV/Share(Rs) | 101.48 | 95.91 | 81.81 | 81.04 | 88.18 |
| Tax Rate(%) | 24.80 | 22.21 | 20.03 | 229.73 | 61.78 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 18.39 | 17.49 | 18.70 | 10.04 | 13.16 |
| EBIT Margin(%) | 14.35 | 14.97 | 19.84 | 5.19 | 9.59 |
| Pre Tax Margin(%) | 12.45 | 12.92 | 17.28 | 1.07 | 5.17 |
| PAT Margin (%) | 9.36 | 10.05 | 13.82 | -1.39 | 1.98 |
| Cash Profit Margin (%) | 14.33 | 15.06 | 19.08 | 5.82 | 8.27 |
| Performance Ratios | |||||
| ROA(%) | 5.15 | 5.36 | 7.08 | -0.52 | 0.82 |
| ROE(%) | 8.66 | 9.44 | 12.85 | -0.88 | 1.38 |
| ROCE(%) | 12.01 | 12.50 | 15.61 | 2.72 | 5.36 |
| Asset Turnover(x) | 0.55 | 0.53 | 0.51 | 0.37 | 0.41 |
| Sales/Fixed Asset(x) | 0.60 | 0.56 | 0.54 | 0.40 | 0.48 |
| Working Capital/Sales(x) | -3.94 | -38.57 | -41.49 | -20.30 | -2.83 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.68 | 1.77 | 1.86 | 2.50 | 2.09 |
| Receivable days | 32.02 | 31.70 | 30.96 | 41.50 | 39.44 |
| Inventory Days | 6.10 | 7.12 | 6.37 | 7.02 | 5.31 |
| Payable days | 162.59 | 172.53 | 162.58 | 214.28 | 255.83 |
| Valuation Parameters | |||||
| PER(x) | 52.93 | 33.33 | 39.49 | - | 164.25 |
| PCE(x) | 32.09 | 20.69 | 20.10 | 64.09 | 24.83 |
| Price/Book(x) | 4.14 | 2.71 | 3.55 | 2.46 | 1.43 |
| Yield(%) | 0.24 | 0.38 | - | - | - |
| EV/Net Sales(x) | 4.64 | 3.17 | 3.93 | 3.94 | 2.29 |
| EV/Core EBITDA(x) | 24.47 | 17.17 | 20.50 | 35.21 | 16.01 |
| EV/EBIT(x) | 32.32 | 21.18 | 19.81 | 75.91 | 23.86 |
| EV/CE(x) | 3.75 | 2.51 | 3.15 | 2.15 | 1.32 |
| M Cap / Sales | 4.60 | 3.12 | 3.83 | 3.73 | 2.05 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 9.45 | 10.14 | 41.87 | -13.00 | 3.65 |
| Core EBITDA Growth(%) | 12.28 | 6.09 | 143.08 | -31.89 | 108.48 |
| EBIT Growth(%) | 4.89 | -16.91 | 442.43 | -52.93 | 96.01 |
| PAT Growth(%) | 1.93 | -19.87 | 1,506.38 | -161.39 | 140.90 |
| EPS Growth(%) | 1.72 | 6.06 | 605.74 | -289.46 | 119.38 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.11 | 0.10 | 0.16 | 0.21 | 0.20 |
| Current Ratio(x) | 0.45 | 0.88 | 0.89 | 0.84 | 0.36 |
| Quick Ratio(x) | 0.41 | 0.78 | 0.79 | 0.78 | 0.33 |
| Interest Cover(x) | 7.55 | 7.30 | 7.73 | 1.26 | 2.17 |
| Total Debt/Mcap(x) | 0.03 | 0.04 | 0.04 | 0.08 | 0.14 |
Compare Financial Ratios of peers of FORTIS HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FORTIS HEALTHCARE | ₹55,179.2 Cr | 7.7% | 12.4% | 72.2% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹113,462.0 Cr | 2.3% | 19.4% | 67% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹105,335.0 Cr | 0.8% | 7.1% | 28.7% | Stock Analytics | |
| GLOBAL HEALTH | ₹28,968.5 Cr | -1.8% | 0.2% | 13% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹26,029.4 Cr | -2.6% | 2% | 9.5% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹25,924.7 Cr | 3.1% | 6.3% | 28% | Stock Analytics | |
FORTIS HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FORTIS HEALTHCARE | 7.7% |
12.4% |
72.2% |
| SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses
